Artículo

Becú-Villalobos, D.; Thyssen, S.M.; Rey, E.B.; Lux-Lantos, V.; Libertun, C. "Octopamine and Phenylethylamine Inhibit Prolactin Secretion both In Vivo and In Vitro" (1992) Proceedings of the Society for Experimental Biology and Medicine. 199(2):230-235
Estamos trabajando para incorporar este artículo al repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

Trace amines are a group of biogenic amines that are present in neural tissue in concentrations ranging from 0.1 to 100 ng/g. In the present work, we examined the action of two trace amines, octopamine and phenylethylamine, which are found in the hypothalamus, on pituitary hormone secretion in different experimental situations In vivo and in dispersed anterior pituitary cells. Both octopamine and phenylethylamine decreased high prolactin levels due to swimming or immobilization stress without affecting other adenohypophysial hormones. With regard to the hypoprolactinemic potencies in the immobilization stress model, it was observed that p-tyramine, another trace amine, was as potent as octopamine. Phenylethylamine was the least effective. To evaluate the site of action of the effect described, the three trace amines were tested in dispersed anterior pituitary cell cultures in vitro. Tyramine and octopamine reduced prolactin secretion in a concentration-dependent manner, at concentrations of 10–8 to 10–5M, whereas the hypoprolactinemic effect observed for phenylethylamine was very weak. In pharmacologic experiments, neither octopamine nor phenylethylamine reduced prolactin release when dopaminergic receptors were blocked. This could mean that their hypoprolactinemic action was mediated through the release of dopamine, or it could be a direct action at a dopaminergic receptor. This is the first description of a specific endocrine action both in vivo and in vitro for octopamine and phenylethylamine. Further studies are needed to ascertain the physiologic or pathologic implication of these findings. © 1992, SAGE Publications. All rights reserved.

Registro:

Documento: Artículo
Título:Octopamine and Phenylethylamine Inhibit Prolactin Secretion both In Vivo and In Vitro
Autor:Becú-Villalobos, D.; Thyssen, S.M.; Rey, E.B.; Lux-Lantos, V.; Libertun, C.
Filiación:Laboratorio de Neuroendocrinologia, Institute de Biologia y Medicina Experimental, 1428 Buenos Aires, Argentina
Palabras clave:haloperidol; octopamine; phenethylamine; tyramine; article; intraperitoneal drug administration; nonhuman; priority journal; prolactin release; rat; Analysis of Variance; Animal; Comparative Study; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Hyperprolactinemia; Immobilization; In Vitro; Male; Octopamine; Phenethylamines; Pituitary Gland; Prolactin; Rats; Rats, Inbred Strains; Support, Non-U.S. Gov't; Swimming; Tyramine
Año:1992
Volumen:199
Número:2
Página de inicio:230
Página de fin:235
DOI: http://dx.doi.org/10.3181/00379727-199-43352
Título revista:Proceedings of the Society for Experimental Biology and Medicine
Título revista abreviado:Proc. Soc. Exp. Biol. Med.
ISSN:00379727
CAS:haloperidol, 52-86-8; octopamine, 104-14-3; phenethylamine, 64-04-0; tyramine, 51-67-2, 60-19-5; Dopamine, 51-61-6; Haloperidol, 52-86-8; Octopamine, 104-14-3; Phenethylamines; Prolactin, 9002-62-4; Tyramine, 51-67-2
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00379727_v199_n2_p230_BecuVillalobos

Referencias:

  • Boulton, A.A., The trace amines: Recent overview and future pointers (1985) Neuropsychopharmacology of the Trace Amines, p. 3. , Boulton AA, Bieck PR, Maitre L, Riederer P, Eds, Clifton, NJ: Humana Press
  • Dewhurst, W.G., Trace Amines: The early years (1984) Neurobiology of the Trace Amines, p. 3. , Boulton AA, Baker GL, Dewhurst WG, Sandler M, Eds, Clifton, NJ: Humana Press
  • Molinoff, P.B., Axelrod, J., Distribution and turnover of octopamine in tissues (1972) J Neurachem, 19, pp. 157-163
  • Durden, D.A., Philips, S.R., Kinetic measurement of the turnover rate of phenylethylamine and tryptamine “in vivo” in the rat brain (1980) J Neurochem, 34, pp. 1725-1732
  • Hicks, T.P., Locock, R.A., Jason, G.W., Is octopamine a “false transmitter”? Regional distribution and serial changes in octopamine and noradrenaline following locus coeruleus lesions (1987) Brain Res, 421, pp. 315-324
  • Hicks, T.P., McLennan, H., Comparison of the actions of octopamine and catecholamines on single neurons of the rat cerebral cortex (1978) Br J Pharmacol, 64, pp. 485-491
  • Ibrahim, K.E., Couch, M.W., Williams, C.M., Fregly, M.J., Midgley, J.M., m-Octopamine: Normal occurrence with p-octopamine in mammalian sympathetic nerves (1985) J Neurochem, 44, pp. 1862-1866
  • Trendelenburgh, V., Muskus, A., Fleming, W.W., Alonso, G., de la Sierra, B., Effect of cocaine, denervation and decentralization on the response of the nictitating membrane to various sympathomimetic amines (1962) J Pharmacol Exp Ther, 138, pp. 181-193
  • Axelford, J., Saavedra, J.M., Octopamine (1977) Nature, 265, pp. 501-504
  • Danielson, T.J., Boulton, A.A., Robertson, H.A., m-Octopamine, p-octopamine and phenylethylamine in mammalian brain: A sensitive. specific assay and effects of drugs (1977) J Neurochem, 29, pp. 1131-1135
  • David, J.C., Relationship between phenolamines and catecholamines during rat embryonic development in vivo and in vitro (1984) J. Neurochem, 43, pp. 668-674
  • Durden, D.A., Phillips, S.R., Boulton, A.A., Identification and distribution of β-phenylethylamine in the rat (1973) Can J Biochem, 51, pp. 995-1002
  • Karoum, F., Nasrallah, H., Potkin, S., Chuang, L., Moyer-Schwing, J., Phillips, I., Wyatt, R.J., Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine and brain (1979) J Neurochem, 33, pp. 201-212
  • Kellar, K.J., Cascio, C.S., Tryptamine and phenylethylamine recognition sites in brain (1986) Neuromethods, Receptor Binding, 4, p. 119. , Boulton AA, Baker GB, Hrdine PD, Eds, Clifton, NJ: Humana Press
  • Hanger, F.L., Skolinick, P., Paul, S.M., Specific (3H)-beta-phenyleth-ylamine binding sites in rat brain (1982) Eur J Pharmacol, 83, pp. 147-148
  • Yang, H.Y.T., Neff, N.H., β-Phenylethvlamine, a specific substrate for type B monoamino oxydase in the brain (1973) J Pharmacol Exp Ther, 187, pp. 365-371
  • Wu, P.H., Boulton, A.A., Metabolism, distribution and disappearance of injected β-phenylethylamine in the rat (1975) Can J Biochem, 53, pp. 42-50
  • Loo, Y.H., Serotonin deficiency in experimental hyperphenylalaninemia (1974) J Neurochem, 23, pp. 139-147
  • Mogilnicka, E., Braestrup, C., Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenylethylamine and apomorphine (1976) J Pharmac Pharmacol, 28, pp. 253-255
  • Fuxe, K., Grobecker, H., Johnsson, J., The effect of β-phenylethylamine on central and peripheral monoamine-containing neurons (1967) Eur J Pharmacol, 2, pp. 202-207
  • Langer, S.Z., Arbilla, S., Niddam, R., Benkirane, S., Baud, P., Pharmacological profile of β-phenylethylamine on dopaminergic and noradrenergic neurotransmission in rat cerebral slices: Comparison with amphetamine and other trace amines (1985) Neuropsychopharmacology of the Trace Amines, p. 27. , Boulton AA, Bieck PR, Maitre L, Riederer P, Eds, Clifton, NJ: Humana Press
  • Randrup, A., Munkvad, I., Dopa and other naturally occurring substances as causes of stereotypy and rang in rats (1966) Acta Psychiatr Scand, 42, pp. 193-199. , (suppl 191)
  • Dourish, C.T., Cooper, S.J., Environmental experience produces qualitative changes in the stimulant effects of β-phenylethylamine in rats (1984) Psychopharmacology, 84, pp. 132-135
  • Dourish, C.T., Boulton, A.A., The effects of acute and chronic administration of β-phenylethylamine on food intake and body weight in rats (1981) Prog Neuropsychopharmacol, 5, pp. 411-417
  • Sandler, R.L., Reynolds, G.P., Does phenylethylamine cause schizophrenia? (1976) Lancet, 1, pp. 70-71
  • Becú-Villalobos, D., Lacau de Mengido, I.M., Libertun, C., p-Tyra-mine, a natural amine, inhibits prolactin release in vivo (1985) Endocrinology, 116, pp. 2044-2048
  • Becú-Villalobos, D., Libertun, C., Differential responsiveness of LH and prolactin to p-tyramine in male and female rat (1988) Proc Soc Exp Biol Med, 188, pp. 103-107
  • Becú-Villalobos, D., Vacas, M.I., Libertun, C., Prolactin inhibition by p-tyramine in the male rat: Site of action (1987) Endocrinology, 120, pp. 2297-2301
  • Simpkins, J.W., Millard, W.J., Gabriel, S.M., Soltis, E.E., Noradrenergic methods in neuroendocrinology (1985) Handbook of Pharmacologic Methodologies for the Study of the Neuroendocrine System, p. 1. , Steger RW, Johns A, Eds, Boca Raton, FL: CRC Press
  • Henry, D.P., Russell, W.L., Clemens, J.A., Plebus, L.A., Phenylethylamines and p-tyramine in the extracellular space of the rat brain: Quantification using a new radioenzymatic assay and in situ microdialysis. Trace Amines (1988) Comparative and Clinical Neurobiology, p. 239. , Boulton AA, Juorio AV, Downer RGH, Eds, Clifton, NJ: Humana Press
  • Ben-Jonathan, N., Peleg, E., Hoefer, M.T., Optimization of culture conditions for short-term pituitary cell culture (1983) Methods in Enzymology, Hormone Action, 193, p. 249. , Conn PM, Ed, New York: Academic Pres
  • David, J.C., Augmentation du taux de phenylethanolamine, m-octopamine et p-octopamine au niveau de l'hypothalamus et de la tige cérébrale de rats genetiquement hypertendus (S.H.R. Kyoto) (1978) CR Acad Sci, 287, pp. 1293-1295
  • Fischer, J.E., Baldessarini, R.J., False neurotransmitters and hepatic failure (1971) Lancet, 75, pp. 75-80
  • Lloyd, K.G.P., Davidson, L., Price, K., McChung, H.S., Gall, D.G., Catecholamines and octopamine concentrations in brains of patients with Reye's syndrome (1977) Neurology, 27, pp. 985-988
  • Sandler, M., Ruthven, C.R.J., Goodwin, G.L., Reynolds, G.P., Rao, V.A.R., Coppens, A., Deficient production of tyramine and octopamine in cases of depression (1979) Nature, 278, pp. 357-358
  • Sedlock, M.L., Ravitch, J., Edwards, D.J., The effects of imipramine and iprindole on the metabolism of octopamine in the rat (1985) Neuropharmacology, 24, pp. 705-708
  • Fischer, E., Spatz, H., Heller, B., Reggiane, H., Phenylethylamine content of human urine and rat brain, its alterations in pathological conditions and after drug administration (1972) Experientia, 28, pp. 307-308
  • Sabelli, H.C., Mosnaim, A.D., Phenylethylamine hypothesis of affective behavior (1974) Am J Psychiatry, 131, pp. 695-699
  • Karoum, F., Linnoila, M., Potter, W.Z., Fluctuating high urinary phenylethylamine excretion rate in some bipolar affective disorder patients (1982) Psychiatry Res, 6, pp. 215-222
  • Reynolds, G.P., Phenylethylamine—a role in mental illness? (1979) TINS, 2, pp. 265-268
  • Wolf, M.E., Mosnaim, A.D., Phenylethylamine in neuropsychiatric disorders (1983) Gen Pharmacol, 14, pp. 385-390
  • De Leo, V., Cella, S.G., Camanni, F., Genazzani, A.R., Muller, E.E., Prolactin lowering effect of amphetamine in normoprolactinemic subjects in physiological and pathological hyperprolactinemia (1983) Horm Metab Res, 15, pp. 439-443
  • Oldendorf, H., Brain uptake of radiolabelled amino acids, amines and hexoses after arterial injection (1971) Am J Physiol, 221, pp. 1629-1639
  • Demarest, K.T., Moore, K.E., Riegle, G.D., Acute restraint stress decreases dopamine synthesis and turnover in the median eminence: A model for the study of the inhibitory neuronal influences on tuberoinfundibular dopaminergic neurons (1985) Neuroendocrinology, 41, pp. 437-444
  • Shin, S.H., Physiological evidence for the existence of prolactin releasing factor: Stress-induced prolactin secretion is not linked to dopaminergic receptors (1980) Neuroendocrinology, 31, pp. 375-379
  • Fawcett, J., Sabelli, H., Gusovsky, F., Epstein, P., Javaid, J., Jeffries, H., Phenylethylame mechanisms in maprotiline antidepressant effect [Abstract 5110] (1983) Fed Proc, 42, p. 1164

Citas:

---------- APA ----------
Becú-Villalobos, D., Thyssen, S.M., Rey, E.B., Lux-Lantos, V. & Libertun, C. (1992) . Octopamine and Phenylethylamine Inhibit Prolactin Secretion both In Vivo and In Vitro. Proceedings of the Society for Experimental Biology and Medicine, 199(2), 230-235.
http://dx.doi.org/10.3181/00379727-199-43352
---------- CHICAGO ----------
Becú-Villalobos, D., Thyssen, S.M., Rey, E.B., Lux-Lantos, V., Libertun, C. "Octopamine and Phenylethylamine Inhibit Prolactin Secretion both In Vivo and In Vitro" . Proceedings of the Society for Experimental Biology and Medicine 199, no. 2 (1992) : 230-235.
http://dx.doi.org/10.3181/00379727-199-43352
---------- MLA ----------
Becú-Villalobos, D., Thyssen, S.M., Rey, E.B., Lux-Lantos, V., Libertun, C. "Octopamine and Phenylethylamine Inhibit Prolactin Secretion both In Vivo and In Vitro" . Proceedings of the Society for Experimental Biology and Medicine, vol. 199, no. 2, 1992, pp. 230-235.
http://dx.doi.org/10.3181/00379727-199-43352
---------- VANCOUVER ----------
Becú-Villalobos, D., Thyssen, S.M., Rey, E.B., Lux-Lantos, V., Libertun, C. Octopamine and Phenylethylamine Inhibit Prolactin Secretion both In Vivo and In Vitro. Proc. Soc. Exp. Biol. Med. 1992;199(2):230-235.
http://dx.doi.org/10.3181/00379727-199-43352